This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Bristol-Myers Squibb Company (BMY)

NYSE: Health Care

$64.50 -1.26 | -1.92%
03/31/15 - 4:00:00 PM ET
  • Prev Close: 65.76
  • Day's Open: 65.47
  • Volume: 7.81M
  • Avg Vol: 6.39M
  • Shares Outstanding: 1.66B
  • Mkt Cap: 108.77B
  • Div: $0.37
  • Div Yield: 2.30%
  • P/E: 54.38
  • EPS: 1.21
BMY Day's Range
$64.50
$65.74
BMY 52 Week Range
$46.30
$69.20
BMY Business Summary
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.View BMY key stats
Bristol-Myers Squibb Company - BMY - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Bristol-Myers Squibb Company as a Hold with a ratings score of C.
Report Snippet: We rate Bristol-Myers Squibb Company (BMY) a Hold. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.
Rating: 2.67 out of 5, 'C' Hold.
You can view the full analysis from the report here:
BMY Rating Report
BMY Earnings Transcripts
  • Bristol-Myers-Squibb (BMY) Earnings Report: Q4 2014 Conference Call Transcript
    TheStreet | 01/27/15 - 10:18 PM EST
  • Bristol Myers Squibb (BMY) Earnings Report: Q3 2014 Conference Call Transcript
    TheStreet | 10/24/14 - 04:27 PM EDT
BMY Performance as of Prev. Close
YTD
11.40%
3-Mo
10.73%
1-Yr
26.90%
3-Yr
94.84%
BMY EPS Performance
1-Yr Ago
1.21
2-Yrs Ago
1.56
3-Yrs Ago
1.17
BMY Percentage in these ETFs
1.950%
0.930%
0.370%
0.210%
0.130%
BMY News

BMY Bristol-Myers Squibb Company

Analysts Ratings for BMY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 9 9 9
Moderate Buy 0 0 0 0
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET BMY ANALYST REPORT

Brokerage Partners

BMY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs